David Baram: Founder and CEO of EmendoBio

Portrait of David Baram

David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service

Agents A Palette of Therapies video screenshot
Agenus

A Palette of Therapies

Danbury Hospital Annual Report Cover
Danbury Hospital

A Prescription for the Future